netFormulary North Central London NHS
Joint Formulary  
 Search
 Formulary Chapter 11: Eye - Full Chapter
11.08.02  Expand sub section  Ocular diagnostic and peri-operative preparations and photodynamic treatment
11.08.02  Expand sub section  Ocular diagnostic preparations
11.08.02  Expand sub section  Ocular peri-operative drugs
Acetylcholine intra-ocular irrigation (Miochol-E, Miphtel)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Secondary care notes

  • NMUH approvals:
    • Nil
  • RFL approvals:
    • Nil
  • RNOH approvals
    • Not applicable
  • UCLH approvals:
  • WH approvals:
    • Nil
 
   
Apraclonidine ophthalmic solution (Iopidine)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Secondary care notes

  • NMUH approvals:
    • Apraclonidine 0.5% used short-term to delay laser treatment or surgery in patients with glaucoma not adequately controlled by another drug
    • See link below   
  • RFL approvals:
    • 1% restricted to Opthalmology
  • RNOH approvals
    • Not applicable
  • UCLH approvals:
  • WH approvals:
    • Apraclonidine 1% preservative free is restricted to Ophthalmology
 
Link  NCL JFC: Open Angle Glaucoma And Ocular Hypertension Glaucoma Prescribing Guideline
   
Diclofenac Sodium 0.1% eye drops - single use (Voltarol Ophtha)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Secondary care notes

  • NMUH approvals:
    • Not applicable
  • RFL approvals:
    • Restricted to Opthalmology
  • RNOH approvals:
    • Not applicable
  • UCLH approvals:
  • WH approvals:
    • Nil
 
   
Ketorolac 0.5% eye drops (Acular)
(Ophthalmic)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Approved for:

  • Treatment of inflammation post cataract surgery in patients unable to tolerate topical corticosteroids
  • Prophylaxis of cystoid macular oedema (CMO) in high-risk patients

Secondary care notes

  • NMUH approvals:
    • Restricted to Consultant Ophthalmologist use only.
  • RFL approvals:
    • Not applicable
  • RNOH approvals:
  • UCLH approvals:
  • WH approvals:
    • Restricted to ophthalmology
 
   
11.08.02  Expand sub section  Subfoveal choroidal neovascularisation
11.08.02  Expand sub section  Vitreomacular traction to top
 ....
 Non Formulary Items
Bromfenac 900micrograms/ml eye drops

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for post-cataract surgery (JFC April 2013)

Not approved for prophylaxis of cystoid macular oedema (CMO) in high-risk patients (JFC April 2013)

 
Diclofenac Sodium 0.1% eye drops  (Voltarol Ophtha multidose)
(Ophthalmic)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Flurbiprofen 0.03% eye drops  (Ocufen)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Nepafenac eye drops  (Nevanac)
(Ophthalmic)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary